Arbutus Biopharma
Emily Thi has extensive work experience in the biopharmaceutical industry. Emily started their career at Tekmira Pharmaceuticals in 2013, where they worked as a Postdoctoral Scientist and later as a Scientist in the Research department. In 2015, they joined Arbutus Biopharma Corporation as a Senior Scientist in In Vivo Pharmacology and Macro-Molecular Discovery. Emily then progressed to the role of Principal Scientist and currently holds the position of Senior Director of Immunobiology & Biomarkers Research.
Emily Thi has a Ph.D. in Experimental Medicine from The University of British Columbia.
This person is not in any offices
Arbutus Biopharma
2 followers
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).